NI

Nextech Invest Portfolio holdings

AUM $528M
This Quarter Return
-20.47%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$350M
AUM Growth
+$350M
Cap. Flow
+$65.3M
Cap. Flow %
18.64%
Top 10 Hldgs %
90.47%
Holding
14
New
3
Increased
1
Reduced
–
Closed
–

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$24.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.2M
3
RLAY icon
Relay Therapeutics
RLAY
$14.2M
4
BPMC
Blueprint Medicines
BPMC
$12M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$7.1B
$100M 28.69% 3,939,529 +971,315 +33% +$24.8M
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$54.1M 15.45% 13,104,424 – –
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$33.9M 9.67% 3,008,243 – –
PMVP icon
4
PMV Pharmaceuticals
PMVP
$74.2M
$28.9M 8.24% 1,385,807 – –
TYRA icon
5
Tyra Biosciences
TYRA
$675M
$26.9M 7.69% 2,518,582 – –
ARVN icon
6
Arvinas
ARVN
$568M
$19.3M 5.52% 287,251 – –
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.2M 4.07% +173,300 New +$14.2M
RLAY icon
8
Relay Therapeutics
RLAY
$619M
$14.2M 4.06% +475,485 New +$14.2M
CGEM icon
9
Cullinan Oncology
CGEM
$445M
$12.8M 3.65% 1,221,145 – –
BPMC
10
DELISTED
Blueprint Medicines
BPMC
$12M 3.43% +188,228 New +$12M
KRON
11
DELISTED
Kronos Bio
KRON
$10.5M 3% 1,451,537 – –
CCCC icon
12
C4 Therapeutics
CCCC
$185M
$9.12M 2.6% 375,857 – –
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$7.05M 2.01% 611,310 – –
SPRY icon
14
ARS Pharmaceuticals
SPRY
$1.15B
$6.7M 1.91% 1,910,029 – –